April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Time-Lapse Imaging of Retinal Angiogenesis Demonstrates That Anecortave Desacetate Attenuates Both the Development and Progression of Neovascular Sprouting
Author Affiliations & Notes
  • M. Nukada
    University of Kyoto, 54 kawaramachi shogoin sakyoku kyoto city, Japan
  • N. Unoki
    University of Kyoto, 54 Kawaramachi Shogoin Sakyoku Kyoto City, Japan
  • K. Ogino
    University of Kyoto, 54 Kawaramachi Shogoin Sakyoku Kyoto City, Japan
  • T. Murakami
    University of Kyoto, 54 Kawaramachi Shogoin Sakyoku Kyoto City, Japan
  • N. Yoshimura
    University of Kyoto, 54 Kawaramachi Shogoin Sakyoku Kyoto City, Japan
  • Footnotes
    Commercial Relationships  M. Nukada, None; N. Unoki, None; K. Ogino, None; T. Murakami, None; N. Yoshimura, None.
  • Footnotes
    Support  Alcone
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 47. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Nukada, N. Unoki, K. Ogino, T. Murakami, N. Yoshimura; Time-Lapse Imaging of Retinal Angiogenesis Demonstrates That Anecortave Desacetate Attenuates Both the Development and Progression of Neovascular Sprouting. Invest. Ophthalmol. Vis. Sci. 2010;51(13):47.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Neovascularization is a dynamic phenomenon, whereas the kinetics of retinal angiogenesis remains ill-defined. Here we evaluated the dynamics of neovascular sprouting and its molecular mechanisms in the retinal angiogenesis treated with an angiostatic steroid, anecortave desacetate (AD).

Methods: : Retinas were isolated from 7- to 8- week old C57BL6/J mice and cultured for 96 hours in the presence or absence of AD, followed with each additional experiment. For in vivo experiments, AD was injected intraperitoneally into C57BL6/J mice on postnatal day 2 (P2), and the retinas were isolated on P4. After the fixation and permeation, immunohistochemistry was performed with fluorescent 2nd antibodies. Real time PCR was performed for the measurements of mRNA levels. Time-sequential images were obtained at every 15 minute using confocal microscopy, and the movements of neovascular sprouts were quantified

Results: : AD treatment significantly reduced the number of neovascular sprouts in retinal explants in a dose dependent manner. Time-lapse imaging demonstrated that AD suppressed both the development and the elongation of sprouts, and the motility of the leading edges in tip cells. AD treatment further disturbed the filopodial extension and significantly decreased the transcriptional levels of KDR and platelet-derived growth factor-B (PDGFB), which are highly expressed in tip cells, suggesting the tip cell dysfunction. The transcriptional level of stromal derived factor-1 (SDF-1), which regulates tip cell motility, was also reduced by AD, whereas AD did not alter the expression of its receptor, CXCR4. Additionally, immunostaining and electron microscopy demonstrated the immature basement membrane in neovascular sprouts treated with AD. Further in vivo experiments showed that AD inhibited the neovascularization and filopodial extension in tip cells in retinal vascular development. These data suggest that AD suppresses both development and progression of sprouting angiogenesis.

Conclusions: : AD attenuated VEGF-induced retinal angiogenesis, mediated via the suppression of the development and progression of neovascular sprouts and tip cell motility at least partially.

Keywords: retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×